Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dose-Escalating and Safety Study of CP-461 in Patients With Chronic Lymphocytic Leukemia

NCT00036257 is registered in ClinicalTrials.gov with Astellas Pharma Inc as lead sponsor.

NCT NCT00036257
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00036257 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dose-Escalating and Safety Study of CP-461 in Patients With Chronic Lymphocytic Leukemia
Lead sponsor
Astellas Pharma Inc
Phase
Phase 1
Overall status
Completed
Start date
March 31, 2002
Completion date
April 30, 2003
Enrollment
15
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

chronic lymphocytic leukemia